Clinical Trials Browser

Terminated × Pancreatic Neoplasms × cabiralizumab × Clear all

NCT03599362 2021-10-19

Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer

Phase 2 Terminated

7 enrolled 10 charts

Gastrointestinal

Pancreatic Neoplasms